Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 10

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Clinical and Genetic Associations in Cephalosporin‐Induced Liver Injury: Insights From the Drug‐Induced Liver Injury Network

Vuppalanchi, Raj, Li, Yi‐Ju, Rockey, Don C., Halegoua‐DeMarzio, Dina, Fontana, Robert J., Bonkovsky, Herbert L., Koh, Christopher, Odin, Joseph, Barnhart, Huiman, Hoofnagle, Jay H., Drug‐Induced Liver Injury Network (DILIN) · 2025 · Alimentary Pharmacology & Therapeutics

Abstract

Introduction: Cephalosporins are widely prescribed antibiotics due to their efficacy and safety. Although rare, idiosyncratic drug‐induced liver injury (DILI) has been reported with their use. Here, we characterise the clinical features and HLA associations of cephalosporin‐related liver injury. Methods: Between Jan 1, 2004, and Nov 2, 2022, a total of 2347 cases of DILI were enrolled in the DILIN study, of which 1854 were adjudicated as probable, highly likely, or definite. HLA sequencing was performed, and association with the risk of DILI was examined. Results: 58 cases (3%) were attributed to different cephalosporins, including cefazolin ( n = 40), cephalexin ( n = 4), ceftriaxone ( n = 3), cefdinir ( n = 3), cefuroxime ( n = 3), and five other individual agents. Clinical features included a self‐limited course with a mixed or cholestatic biochemical pattern without hypersensitivity features occuring in 1 to 4 weeks. Most striking was the phenotype of cefazolin and other parenteral cephalosporins given as a single dose with the onset of jaundice, fatigue, and itching 1 to 3 weeks later. In the total cohort, HLA‐A*02:01 was significantly associated with an increased risk of cephalosporin‐induced liver injury (OR: ~2.5–2.7, P < 0.0001). The association was strongest with cefazolin, with carrier frequencies of 85% vs. 38% in those with DILI from other drugs. Conclusions: Cephalosporins can cause self‐limited, mixed/cholestatic hepatitis that arises after a short course of therapy with a latency of up to 3 weeks with cefazolin. Cephalosporin‐induced liver injury is associated with the HLA‐A*02:01 allele, which is linked to more severe liver injury at the onset of illness.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.70284

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Consort diagram. Cases enrolled in the DILI prospective study (Clinicaltrial.gov ID: NCT00345930) and those caused by cephalosporins during the study period are depicted. 1854 cases were deemed as “high confidence” (rated definite, highly likely, or probable) by the DILIN Causality Committee during the study period.
FIGURE 1 Consort diagram. Cases enrolled in the DILI prospective study (Clinicaltrial.gov ID: NCT00345930) and those caused by cephalosporins during the study period are depicted. 1854 cases were deemed as “high confidence” (rated definite, highly likely, or probable) by the DILIN Causality Committee during the study period.CC BY-NC-ND · PubMed Central
FIGURE 2 Carriage and allele frequency of HLA‐A*02:01 in Cefazolin‐induced DILI. (A) Carriage frequency and (B) allele frequency of cefazolin cases as a function of causality likelihood (highly likely vs. probable vs. possible vs. unlikely) and compared to other cephalosporins or control groups, that is, other DILI or non‐Hispanic White subjects with rates reported in Population HLA allele frequencies obtained from the Allele Frequency Net Database (AFND) for mixed ancestry samples and non‐Hispanic Whites. Of note, there was one Hispanic White subject in the study cohort who did not express HLA‐A*02:01, while the single Black subject was heterozygous for HLA‐A*02:01.
FIGURE 2 Carriage and allele frequency of HLA‐A*02:01 in Cefazolin‐induced DILI. (A) Carriage frequency and (B) allele frequency of cefazolin cases as a function of causality likelihood (highly likely vs. probable vs. possible vs. unlikely) and compared to other cephalosporins or control groups, that is, other DILI or non‐Hispanic White subjects with rates reported in Population HLA allele frequencies obtained from the Allele Frequency Net Database (AFND) for mixed ancestry samples and non‐Hispanic Whites. Of note, there was one Hispanic White subject in the study cohort who did not express HLA‐A*02:01, while the single Black subject was heterozygous for HLA‐A*02:01.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. Bui T., 2024, StatPearls
  2. 2012, LiverTox: Clinical and Research Information on Drug‐Induced Liver Injury
  3. Gilani B., 2024, HLA B 5701 Testing

Cited by

Metadata

Authors
Vuppalanchi, R., Li, Y., Rockey, D. C., Halegoua‐DeMarzio, D., Fontana, R. J., Bonkovsky, H. L., Koh, C., Odin, J., Barnhart, H., Hoofnagle, J. H., & Drug‐Induced Liver Injury Network (DILIN)
Affiliations
  • Indiana University School of Medicine Indianapolis Indiana USA
  • Duke University School of Medicine Durham North Carolina USA
  • Medical University of South Carolina Charleston South Carolina USA
  • Sidney Kimmel Medical College at Thomas Jefferson University Philadelphia Pennsylvania USA
  • University of Michigan Ann Arbor Michigan USA
  • Atrium Health Wake Forest Baptist and Wake Forest University School of Medicine Winston‐Salem North Carolina USA
  • National Institute of Diabetes and Digestive and Kidney Diseases Bethesda Maryland USA
  • Icahn School of Medicine at Mount Sinai New York New York USA
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2025-07-20
Volume
62
Issue
10
Pages
1012-1022
ISSN
  • 0269-2813
  • 1365-2036
Cited by
10
References
29
Language
en
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (U01DK065211, U01DK065184, U01DK065201, U01DK083020, U01DK083027, U24DK065176)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.